Pharmacokinetics of Tiotropium in Subjects With COPD
Study Title
- To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Teva Identifier
- TBB-COPD-201
ClinicalTrials.gov Identifier
- NCT01785433
Study Status
- Completed
Trial Condition(s)
- COPD
Interventions
- Drug: Tiotropium HFA BAI 4.5 mcg | Drug: Tiotropium HFA BAI 9.0 mcg | Drug: SPIRIVAֲ® HandiHalerֲ® 18 mcg/day | Drug: Spirivaֲ® Respimatֲ® 5 mcg/day
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 40 Years to 80 Years
Trial Duration
- 01/01/2013 - 08/01/2013
Phase
- Phase 1/2
Study Type
Interventional
